HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus

Area of Science:

• Immunogenetics
• Rheumatology
• Human Genetics

Background:

• Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with a known genetic component.
• Identifying specific genetic markers can elucidate disease mechanisms and susceptibility factors.

Purpose of the Study:

• To investigate the association between Human Leukocyte Antigen (HLA) and complement C4 (C4) gene variants and susceptibility to Systemic Lupus Erythematosus (SLE).
• To explore potential immunogenetic subgroups within SLE based on these associations.

Main Methods:

• Genotyping of HLA-DQA, HLA-DQB, HLA-DR, and C4 variants in 92 SLE patients and 73 healthy controls.
• Statistical analysis including corrected P-values, odds ratios (OR), and 95% confidence intervals (C.I.).
• Empirical logistic test to determine the primary association among linked markers.

Main Results:

• Increased frequencies of HLA-DQA*0501, HLA-DR3, and C4A*Q0 were observed in SLE patients compared to controls.
• These associations were particularly strong in patients with antibodies to both Ro and La antigens.
• Decreased frequencies of HLA-DQB*0501, HLA-DQA*0101, and HLA-DR7 were noted in SLE patients.
• Early disease onset (before age 30) was associated with the DR3-bearing haplotype.
• No significant associations were found with anti-dsDNA, anti-Sm, anti-U1 RNP antibodies, renal disease, or vasculitis.

Conclusions:

• The study highlights specific HLA-DQA, HLA-DR, and C4 variants as potential genetic risk factors for SLE.
• The findings support the concept of immunogenetic heterogeneity within SLE, with distinct subgroups.
• The association with HLA-DQA*0501 appears to be primary, suggesting a direct role for genes in the HLA-DQ region in SLE susceptibility.